Beauty Farm Medical and Health Industry Inc. completed an on-market repurchase of 52,500 ordinary shares on 8 May 2026, paying a total of HK$1.04 million. The transaction was executed on the Hong Kong Stock Exchange at prices ranging from HK$19.57 to HK$20.04 per share, with a volume-weighted average cost of HK$19.89.

Following the buyback, the company’s issued share capital (excluding treasury shares) fell by 0.021% to 249.64 million shares. Treasury shares increased to 1.95 million, while the total number of issued shares remained unchanged at 251.59 million.

The repurchase forms part of a mandate approved on 27 June 2025 that authorises the company to buy back up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 1.95 million shares, equivalent to 0.83% of the company’s issued share base on the mandate date. Under Hong Kong listing rules, Beauty Farm Medical is restricted from issuing new shares or selling treasury shares until 7 June 2026.